Clinically Significant Drug Interactions with New Immunosuppressive Agents

被引:0
|
作者
Christian Mignat
机构
[1] Christian Albrechts University of Kiel,Department of Pharmacology
来源
Drug Safety | 1997年 / 16卷
关键词
Adis International Limited; Tacrolimus; Sirolimus; Mycophenolate Mofetil; Danazol;
D O I
暂无
中图分类号
学科分类号
摘要
Tacrolimus (FK506), mycophenolate mofetil, sirolimus (rapamycin), gusperimus, and monoclonal antibody preparations are new immunosuppressive agents, some of which are already approved for clinical use, while others are currently undergoing clinical trials. The present article provides an overview of adverse drug interactions between these immunosuppressants and other drugs which may be used concomitantly.
引用
收藏
页码:267 / 278
页数:11
相关论文
共 50 条
  • [31] There is a choice for immunosuppressive drug nephrotoxicity: is it time to change?
    Stallone, Giovanni
    Infante, Barbara
    Gesualdo, Loreto
    JOURNAL OF NEPHROLOGY, 2009, 22 (03) : 326 - 332
  • [32] New Immunosuppressive Drugs and Their Role in the Prevention of Islet Xenograft Rejection
    Lars Wennberg
    C. G. Groth
    BioDrugs, 1997, 8 : 307 - 316
  • [33] Assessment of Clinically Relevant Drug Interactions by Online Programs in Renal Transplant Recipients
    Tecen-Yucel, Kamer
    Bayraktar-Ekincioglu, Aygin
    Yildirim, Tolga
    Yilmaz, Seref Rahmi
    Demirkan, Kutay
    Erdem, Yunus
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (10) : 1291 - 1296
  • [34] The role of therapeutic drug monitoring in individualizing immunosuppressive drug therapy: Recent developments
    Oellerich, Michael
    Armstrong, Victor W.
    THERAPEUTIC DRUG MONITORING, 2006, 28 (06) : 720 - 725
  • [35] Nonadherence to immunosuppressive therapy is a significant problem after solid-organ transplantation
    Kawaguchi S.
    Maniruzzaman M.
    Katsuragi K.
    Matsumoto H.
    Iriany I.
    Ito K.
    Hugenberg N.
    Schmidt M.
    Drugs & Therapy Perspectives, 2002, 18 (12) : 19 - 21
  • [36] Impact of single immunosuppressive drug withdrawal on lymphocyte immunoreactivity
    Verma, Meenakshi
    Awdishu, Linda
    Lane, James
    Park, Ken
    Bahur, Bayda
    Lwin, Wint
    McGee, Halvor
    Steiner, Robert
    Finn, Patricia
    Perkins, David
    JOURNAL OF SURGICAL RESEARCH, 2014, 188 (01) : 309 - 315
  • [37] Current opinions on therapeutic drug monitoring of immunosuppressive drugs
    Shaw, LM
    Holt, DW
    Keown, P
    Venkataramanan, R
    Yatscoff, RW
    CLINICAL THERAPEUTICS, 1999, 21 (10) : 1632 - 1652
  • [38] Influence of the new immunosuppressive combinations on arterial hypertension after renal transplantation
    Morales, JM
    KIDNEY INTERNATIONAL, 2002, 62 : S81 - S87
  • [39] Optimizing immunosuppressive drug dosing in pediatric renal transplantation
    Cattaneo, Dario
    Vinks, Alexander A.
    PHARMACOLOGICAL RESEARCH, 2012, 65 (02) : 163 - 167
  • [40] Novel immunosuppressive agents in kidney transplantation
    Cooper, J. E.
    Wiseman, A. C.
    CLINICAL NEPHROLOGY, 2010, 73 (05) : 333 - 343